Navigation Links
Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease
Date:5/27/2009

was also achieved for the early diagnosis of AD (within the first four years of memory loss symptoms). Clinical diagnosis, as confirmed by autopsy, is considerably less accurate in diagnosing AD at such early stages. The BRNI biomarker showed high accuracy when tested with human skin cells from a tissue bank, as well as for samples obtained from the patients with autopsy-confirmed diagnoses.

"Ultimately, the goal of the Blanchette Rockefeller Neuroscience Institute (BRNI) is to cure Alzheimer's disease, and the path to a cure begins with detecting the disease early," said Senator Jay Rockefeller (D-WV), who founded BRNI in honor of his mother. "I applaud the Inverness-BRNI partnership for advancing this research, and I'm deeply proud of the work that goes on every day in West Virginia at BRNI to get us closer to a greater understanding of the disease and a cure."

About BRNI

BRNI is the world's only non-profit institute dedicated to the study of both human memory and diseases of memory. Its primary mission is to accelerate the transfer of neurological discoveries from the lab to the doctor's office where it can benefit patients who suffer from neurological and psychiatric diseases.

BRNI is operated in alliance with West Virginia University in Morgantown as well as in collaboration with other academic institutions such as Johns Hopkins University. West Virginia Senator Jay Rockefeller founded the Institute in memory of his mother, Blanchette Hooker Rockefeller, who died of Alzheimer's disease.

About Inverness Medical Innovations, Inc.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations, Inc. (NYSE: IMA) enables individuals to take charge of improving their health and
'/>"/>

SOURCE Blanchette Rockefeller Neurosciences Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
2. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
3. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
4. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
5. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
6. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
9. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
10. Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
11. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Nektar Therapeutics (Nasdaq: NKTR ) today ... 30, 2014. Cash and investments in marketable ... to $309.1 million at March 31, 2014."The second half of ... look forward to significant milestones for a number of our ... Executive Officer of Nektar. "The first of these is the ...
(Date:7/31/2014)...   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... announced that the Company will release results for the ... before the opening of the U.S. financial markets. The ... at 8:30 a.m. ET to discuss results and highlights ... to be used during the call will be available ...
(Date:7/31/2014)... SARASOTA, Fla. , July 31, 2014 ... announced today that it has initiated the development of ... ; and that it has selected Quotient Clinical, ... United Kingdom (UK) to run its early ... a Clinical Trial Application (CTA) by the end of ...
Breaking Medicine Technology:Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4
... YORK, March 7, 2012  The Alzheimer,s Drug Discovery ... (AFTD) announced today the recipients of their fifth ... Program.   The goal of the ... therapies for frontotemporal degeneration (FTD).  ...
... OAKS, Calif., March 7, 2012  Amgen Inc. ("Amgen") (NASDAQ: ... offering period of the tender offer (the "Offer") by a ... of common stock of Micromet, Inc. ("Micromet") (NASDAQ: ... offering period expired at 12:00 midnight, New York City time, ...
Cached Medicine Technology:Awards for Drug Discovery Research for Frontotemporal Degeneration Announced 2Awards for Drug Discovery Research for Frontotemporal Degeneration Announced 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 4
(Date:7/31/2014)... Most mommy blogs are simple family journals, ... to attract all mothers from all walks of life. ... whether its high fashion or child rearing. When Felicia ... the Internet was so segmented. “I found myself visiting ... and then search Google to get information on another. ...
(Date:7/31/2014)... and saliva tests that help accurately predict recurrences of ... The tests screen for DNA fragments of the human ... mouth or other parts of the body. A description ... issue of JAMA Otolaryngology Head & Neck ... in the year after initial therapy to take an ...
(Date:7/31/2014)... 31, 2014 LDM Global ( http://www.ldmglobal.com ... model that is simplified and predictable with fixed fees ... As a leading international provider of legal discovery management ... has become glaringly apparent that both the courts and ... budgets and the complex pricing structure that plagues the ...
(Date:7/31/2014)... HealthDay Reporter THURSDAY, July 31, ... don,t see themselves that way, which makes achieving a ... new study, 27 percent of children and teens underestimated ... 25 percent of parents underestimated their child,s weight and ... "Efforts to prevent childhood obesity should incorporate education ...
(Date:7/31/2014)... ROCHESTER, Minn. Implementation of an algorithm aimed ... the utilization of computed tomography (CT) scans, without ... have found. The study was recently published in ... is the most common cause of acute abdominal ... becomes inflamed and filled with pus. CT scans ...
Breaking Medicine News(10 mins):Health News:Mommylish Launches Its Website 2Health News:Blood and saliva tests help predict return of HPV-linked oral cancers 2Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:1 in 4 U.S. Kids Underestimate Their Weight, Study Finds 2Health News:1 in 4 U.S. Kids Underestimate Their Weight, Study Finds 3
... , , Magnifies financial and ... impact services and cost to consumers , , ... the proposed Senate health care plan , America,s ... requirements applicable to nonprofit hospitals starting in 2010. According to the ...
... , WASHINGTON, Sept. 16 Today U.S. Sen. ... Health Future Act of 2009" that will be marked-up in ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , , ... subsidize health plans that cover all elective abortions and moves ...
... Researchers suggest strong disapproval of contraception might be a ... birth rates are higher in states with greater levels ... contraception, a new U.S. study suggests. , In the ... Prevention data on teen birth rates with data from ...
... 20-year follow-up study revealed a dramatic drop in liver cancer ... hepatitis B virus at birth, according to a study published ... Cancer Institute . In July 1984, a universal vaccination ... the hepatitis B virus infection, which can predispose to the ...
... , NEW YORK, Sept. 16 The Nielsen ... CLIO Awards, one of the world,s most recognized international advertising and design ... first-ever CLIO Healthcare Awards to be held on ... contemporary, modern space near Highline Park, befitting an innovative awards show. ...
... , ROCHESTER, Minn., Sept. 16 Here ... HealthSource . You may cite this publication as often as you ... is required. Reprinting is allowed for a fee. Include the ... www.bookstore.mayoclinic.com or call toll-free for subscription information, 800-876-8633, extension ...
Cached Medicine News:Health News:Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 2Health News:Family Research Council: Senator Baucus Undermines President Obama's Abortion Funding Claim 2Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 2Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 3Health News:September 2009 Mayo Clinic Women's HealthSource Highlights Ovarian Cancer, Salt and Breaking a Sweat 2Health News:September 2009 Mayo Clinic Women's HealthSource Highlights Ovarian Cancer, Salt and Breaking a Sweat 3Health News:September 2009 Mayo Clinic Women's HealthSource Highlights Ovarian Cancer, Salt and Breaking a Sweat 4Health News:September 2009 Mayo Clinic Women's HealthSource Highlights Ovarian Cancer, Salt and Breaking a Sweat 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: